Mohammad Azam

Cincinnati Children's Hospital Medical Center — United States

Medicine · Health Sciences

21h-index3.5kcitations69works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Myeloid Leukemia Treatments(40), Chronic Lymphocytic Leukemia Research(27), Myeloproliferative Neoplasms: Diagnosis and Treatment(16), Acute Myeloid Leukemia Research(9), Eosinophilic Disorders and Syndromes(9)

Publications69 total

Momelotinib-mediated transcriptional reprogramming induces synthetic lethal interaction with calcineurin-NFAT signaling
Blood·2025
Enhanced antileukemic activity of momelotinib in combination with venetoclax and azacitidine compared to gilteritinib-based combination
Blood·2025Open Access
Negative feedback regulation of nfkb, MAPK, and JAK-STAT drives adaptive resistance to gilteritinib in AML
Blood·2025Open Access
Enhanced Mitochondrial Priming By Momelotinib Confers Superior In Vivo Efficacy in Combination with Venetoclax Compared to Gilteritinib or Ruxolitinib
Blood·2024Open Access
A MULTIDISCIPLINARY APPROACH TO PULMONARY NOCARDIOSIS MANAGEMENT IN AN ACUTE MYELOID LEUKEMIA PATIENT
CHEST Journal·2024· 1 cited
Enhanced MAPK signaling induced by CSF3R mutants confers dependence to DUSP1 for leukemic transformation
Blood Advances·2024· 2 citedOpen Access
DUSP1 Specific Protac Selectively Targets the JAK2 V617F Expressing Cells
Blood·2023Open Access
WHOLE LUNG LAVAGE AFTER LUNG RESECTION FOR MUCORMYCOSIS AND PULMONARY ALVEOLAR PROTEINOSIS IN ACUTE MYELOID LEUKEMIA TREATED WITH HEMATOPOIETIC STEM CELL TRANSPLANT
CHEST Journal·2023Open Access
Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor
Leukemia·2023· 4 cited
MAPK-negative feedback regulation confers dependence to JAK2V617F signaling
Leukemia·2023· 3 citedOpen Access
Recent insights into the role of phospholipase A2 enzymes in modulating cancer growth and development
Elsevier eBooks·2023
Contributors
Elsevier eBooks·2023
In-Situ Fabrication of N-Doped Carbon Dots on Novel Blue-Emitting Y2tiwo8: Ce3+ Nanophosphor for Thermal Sensing and Fingerprint Detection Applications
SSRN Electronic Journal·2023Open Access
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML
Blood Advances·2022· 7 citedOpen Access
PLaCatinG AML1-ETO
Blood·2022· 1 citedOpen Access
Momelotinib is a highly potent inhibitor of FLT3-mutant AML
Blood Advances·2021· 17 citedOpen Access
Momelotinib Is a Highly Potent Inhibitor of FLT3-Mutant AML
Blood·2021
Momelotinib is a highly potent inhibitor of FLT3-mutant AML
2021· 2 citedOpen Access
Adaptive responses to <i>mTOR</i> gene targeting in hematopoietic stem cells reveal a proliferative mechanism evasive to mTOR inhibition
Proceedings of the National Academy of Sciences·2020· 26 citedOpen Access
SWATH‐Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G‐CSFR Signaling
PROTEOMICS - CLINICAL APPLICATIONS·2020· 22 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Meenu Kesarwani(18), George Q. Daley(17), Zachary Kincaid(14), Valentina Nardi(7), Erika Huber(7), H. Leighton Grimes(7), Mohammad Azhar(6), Tomi K. Sawyer(5), Tahir Latif(5), John T. Powers(4), Nathanael S. Gray(4), William C. Shakespeare(4), David C. Dalgarno(3), Sara Rohrabaugh(3), Yi Zheng(3), Pankaj Dwivedi(3), David E. Muench(3), Kenneth D. Greis(3), Gang Huang(3), Mark Wunderlich(3)